Tech Company Financing Transactions

Syndax Pharmaceuticals Funding Round

Syndax Pharmaceuticals closed a $80 million funding round on 8/24/2015. Backers included Delos Capital, Fidelity Management & Research Company and Arrowpoint Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

400 Totten Pond Road 110
Waltham, MA 02451
USA

Phone

(781) 419-1400

Website

www.syndax.com

Email Address

[email protected]

Overview

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Briggs Morrison

        

Chief Financial Officer

Allan Shaw

        

Chief Technical Officer

Peter Ordentlich

        

President

Michael Metzger

        

VP - Operations

Jeannette Hasapidis

        

Browse more venture capital transactions:

Prev: 8/24/2015: Crowdability venture capital transaction
Next: 8/24/2015: Get Smart Content venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary